Avatar

Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maintenance Approaches

By Nina Shah 3 Videos
08/2017
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Association of Northern California Oncologists

ASCO Highlights 2019

Sat, Aug 17, 2019
16:22
Society of Hematologic Oncology Sixth Annual Meeting

FDA Approves Selinexor for Refractory Multiple Myeloma, STORM Study

Feat. S. Jagannath
25:51
The University of Kansas Cancer Center

MM - Overview of Trials Presented at ASH 2018

Feat. A. Abdallah
17:58
Parameswaran Hari

Delivering the Best Initial Treatment for Myeloma: Induction Therapy and...

06:12
Indy Hematology Review

Targeting Mutations in Myeloma with Venetoclax and Development of the Fi...

Feat. K. Anderson
08:40
Surbhi Sidana

Duration of Complete Response Impacts Overall Survival in Multiple Myeloma

08:15
2018 Pan Pacific Lymphoma Conference

Evolution of Myeloma Induction Regimens

Feat. S. Holstein
15:02
Krina Patel

Clinical Trials in Myeloma in 2018

19:41
Peter Voorhees

Approach to the Patient with Refractory & Multiple Relapsed Multiple Mye...

15:11
Ajay Nooka

Early Relapse: Choosing Among Different Second Line Regimens in Myeloma

10:30
Society of Hematologic Oncology Sixth Annual Meeting

Next Questions in Myeloma: Biology, Smoldering Myeloma, High-risk, MRD, ...

Feat. S. Jagannath
13:26
Shaji Kumar

Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma

15:47
Society of Hematologic Oncology Sixth Annual Meeting

Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...

Feat. S. Lonial
12:32
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson
15:10
Krina Patel

Developing CAR T-cells in Multiple Myeloma

09:01
Maria-Victoria Mateos

FDA Approves Once-Weekly Carfilzomib Regimen for Myeloma

15:31
Parameswaran Hari

Refractory and Relapsing Myeloma - When to Treat and Options Available

17:58
City of Hope

Should Everyone Receive Monoclonal Antibodies at First Myeloma Relapse? No!

Feat. J. Mikhael
06:23
Parameswaran Hari

Treating Refractory & Relapsing Myeloma: Current Trends and Recommendati...

17:47
Dana-Farber Cancer Institute

Relapse Refractory Myeloma and Novel Treatments

Feat. N. Raje
33:59
Roswell Park Comprehensive Cancer Center

Minimal Residual Disease (MRD) Testing in Multiple Myeloma. How and When...

Feat. P. McCarthy